Nevro Corp NVRO:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:32 PM EDT
10.28quote price arrow up+0.49 (+5.01%)
Volume
229,057
52 week range
9.76 - 28.89
Loading...
  • Open9.89
  • Day High10.60
  • Day Low9.79
  • Prev Close9.79
  • 52 Week High28.89
  • 52 Week High Date05/15/23
  • 52 Week Low9.76
  • 52 Week Low Date05/10/24

Key Stats

  • Market Cap377.085M
  • Shares Out36.68M
  • 10 Day Average Volume0.80M
  • Dividend-
  • Dividend Yield-
  • Beta0.96
  • YTD % Change-52.09

KEY STATS

  • Open9.89
  • Day High10.60
  • Day Low9.79
  • Prev Close9.79
  • 52 Week High28.89
  • 52 Week High Date05/15/23
  • 52 Week Low9.76
  • 52 Week Low Date05/10/24
  • Market Cap377.085M
  • Shares Out36.68M
  • 10 Day Average Volume0.80M
  • Dividend-
  • Dividend Yield-
  • Beta0.96
  • YTD % Change-52.09

RATIOS/PROFITABILITY

  • EPS (TTM)-2.28
  • P/E (TTM)-4.50
  • Fwd P/E (NTM)-3.85
  • EBITDA (TTM)-89.02M
  • ROE (TTM)-28.49%
  • Revenue (TTM)430.746M
  • Gross Margin (TTM)68.94%
  • Net Margin (TTM)-19.17%
  • Debt To Equity (MRQ)77.10%

EVENTS

  • Earnings Date07/30/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nevro Corp

 

Profile

MORE
Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which...
D. Keith Grossman
Executive Chairman of the Board
Kevin Thornal
President, Chief Executive Officer, Director
Christopher Christoforou
Chief Operating Officer
Roderick Macleod
Chief Financial Officer, Senior Vice President
Address
1800 Bridge Parkway
Redwood City, CA
94065
United States

Top Peers

SYMBOLLASTCHG%CHG
OSUR
OraSure Technologies Inc
5.17+0.31+6.38%
ARAY
Accuray Inc
1.59-0.03-1.54%
BVS
Bioventus Inc
5.75+0.35+6.48%
ATRC
AtriCure Inc
22.98+0.68+3.05%
AORT
Artivion Inc
23.21-0.32-1.36%